World premiere: revolutionary treatment of human tissue

Home
Services
- Serving Bone Banks
- Technology provider
Newsroom
- Press access only
Contact Us
- Location
- Terms

TEXERE Biotech inauguration, 12 Dec 2018, Charleroi, Belgium.

TEXERE Biotech unveils the world’s first fully robotic line
for processing of human tissue.

TEXERE Biotech – Bone Allograft

Bone allograft block (FDBA) by BONEFIDE®

Human tissues, for all

TEXERE Biotech designs and builds forefront robotized processing lines to drive progress and innovation for recycling human tissue.

Get in touch

Rue des Artisans 4A, 6210 Frasnes-Lez-Gosselies, Belgium

+32 (0)71 74 41 86

info@texerebiotech.com

Proudly powered by WordPress | Theme: Sydney by aThemes.

TERMS - PRIVACY - COOKIES

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Reject Accept
Read More

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT